CPHI

China Pharma Holdings Inc. Common Stock (CPHI)

Stock · AMEX · Health Care

$0.9as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$0.625625
Industry
Biotechnology: Pharmaceutical Preparations

About CPHI

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations

Fundamentals

Market cap
$52.06M
P/E (trailing)
P/E (forward)
EPS (trailing)
$-0.56
Dividend yield
Beta
1.02
Avg. volume
52-week range
$0.3818$19.19

How China Pharma Holdings Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$4.14MCost of Revenue$4.28M (103%)SG&A$2.45M (59%)R&D$280.9K (7%)CPHI

Source: 10-K filed Apr 1, 2026 · via SEC EDGAR / Finnhub

China Pharma Holdings Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • CPHI
    China Pharma Holdings Inc. Common Stock
    $0.9
    ▲ 1.12%
    Market cap $52.06MP/E
    $0.3818$19.19
  • RNXT
    RenovoRx Inc. Common Stock
    $1.68
    ▲ 13.18%
    Market cap $51.86MP/E
    $0.7006$1.68
  • SCYX
    SCYNEXIS Inc. Common Stock
    $5.44
    ▼ 1.45%
    Market cap $51.64MP/E
    $3.53$10.48
  • IMMP
    Immutep Limited American Depositary Shares
    $0.3848
    ▲ 1.26%
    Market cap $55.21MP/E
    $0.028$0.47
  • IBO
    Impact BioMedical Inc. Common Stock
    $0.444
    ▲ 0.68%
    Market cap $48.61MP/E 0.49
    $0.37$0.83
  • TCRT
    Alaunos Therapeutics Inc. Common Stock
    $1.56
    ▼ 6.02%
    Market cap $48.60MP/E
    $1.55$4.59
  • MREO
    Mereo BioPharma Group plc American Depositary Shares
    $0.2545
    ▼ 6.43%
    Market cap $47.46MP/E
    $0.2$2.37

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
25.8K
Total value held
$15.7K
Institutional holders
6
Top holders this quarter
  • Unknown12.9K
  • Unknown11.4K
  • Unknown996
  • Unknown389
  • Unknown40
  • Unknown1

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.